NOTICE OF LIMITED COMPETITION EXPLORATORY/DEVELOPMENTAL GRANTS: OVERCOMING BARRIERS TO EARLY PHASE CLINICAL TRIALS Release Date: May 21, 2002 NOTICE: NOT-CA-02-017 National Cancer Institute (http://cancer.gov) The Cancer Centers Branch of the Office of Centers, Training, and Resources at the National Cancer Institute (NCI) invites grant applications from NCI- designated Clinical and Comprehensive Cancer Centers for participation in a pilot program focused on identifying and overcoming barriers to early phase cancer clinical trials. The purpose of this initiative is to enhance national capability to test innovative agents by developing a spectrum of exportable models that NCI Cancer Centers and other organizations can use for increasing and sustaining accrual rates of patients to such trials. NCI Cancer Centers are particularly suited for participation in this pilot program as they have the infrastructure available for conduct of early phase clinical trials, are located in a variety of geographic settings with access to diverse populations, have strong linkages to the communities they serve, and are recognized by industry and the NCI as the best organizations for testing new therapeutic agents. Applicants that are selected for funding must agree to share all information and models that are developed through this initiative with the broader cancer research community and with the NCI. This is a collaborative initiative of the NCI and the Foundation of the National Institutes of Health, Inc., which is in partnership with the following pharmaceutical firms: Aventis, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Novartis. Support will be through the National Institutes of Health exploratory/developmental grant (R21) award mechanism. Approximately $3.0 million in total costs will be made available for each of two years. Half of this amount is to provided by the NCI and half provided through the industrial partners as represented by the Foundation for the National Institutes of Health, Inc. The maximum total cost requested in each cancer center application for support cannot exceed $600,000 per year. The NCI expects to make 5 to 8 awards. NCI staff will contact the current grantees directly regarding other special requirements, application procedures, and format. INQUIRIES Inquiries are encouraged and the opportunity to clarify issues and answer questions is welcome. Inquiries may be directed to: Linda K. Weiss, Ph.D., Chief Cancer Centers Branch Office of Centers, Training, and Resources National Cancer Institute 6116 Executive Boulevard Suite 700 Bethesda, Maryland 20892-8345 Phone: 301 496-8531 Fax: 301 402-0181 Email: lw187q@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |